Characteristics of recombinantly expressed rat and human histamine H3 receptors

European Journal of Pharmacology

Volumn 453, Issue 1, 2002, Pages 33-41

  Wulff, Birgitte S ^a   Hastrup, Sven ^a   Rimvall, Karin ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

(Human); (Rat); 125Iodoproxyfan; cAMP; Histamine H3 receptor; Inverse agonism

Indexed keywords

2 IMIDAZOL 4 YLCYCLOPROPYL(CYCLOHEXYLMETHOXY)CARBOXAMIDE; 3 (4 CHLOROBENZYL) 5 [2 (1H IMIDAZOL 4 YL)ETHYL] 1,2,4 OXADIAZOLE; 4 [2 (5,5 DIMETHYL 1 HEXYNYL)CYCLOPROPYL] 1H IMIDAZOLE; ALPHA METHYLHISTAMINE; ANTIHISTAMINIC AGENT; CIPROXIFAN; CLOBENPROPIT; CYCLIC AMP; GR 175737; GT 2331; GT 2394; HISTAMINE; HISTAMINE AGONIST; HISTAMINE DERIVATIVE; HISTAMINE H3 RECEPTOR; IMETIT; IMMEPIP; IODOPHENPROPIT; IODOPROXYFAN; JB 98064; N (4 CHLOROBENZYL) N (7 PYRROLIDIN 1 YLHEPTYL)GUANIDINE; PARTIAL AGONIST; PERCEPTIN; PROXYFAN; THIOPERAMIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL LINE; CLONING, MOLECULAR; HISTAMINE AGONISTS; HISTAMINE ANTAGONISTS; HUMANS; RATS; RECEPTORS, HISTAMINE; RECEPTORS, HISTAMINE H3; RECOMBINATION, GENETIC;

EID: 0037130988     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02382-8     Document Type: Article

References (52)

1. 3) of histamine receptor. Nature. 302:1983;832-837.
2. 3-receptors. Neuroscience. 23:1987;149-158.
3. 3 receptors regulating acetylcholine-release in rat entorhinal cortex. Br. J. Pharmacol. 114:1995;1518-1522.
4. 1 receptor antagonists. Eur. J. Pharmacol. 387:2000;R5-R7.
5. 3 receptor activation in rats. Br. J. Pharmacol. 119:1996;1656-1664.
6. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
7. 3-receptors in rat cerebral cortical membranes. Br. J. Pharmacol. 114:1995;357-362.
8. 3 receptor antagonists. Bioorg. Med. 6:1996;833-838.
9. 3 receptor. Biochem. J. 355:2001;279-288.
10. 3 receptor - pharmacotherapy targets in gastrointestinal disorders. Drug Dev. 2000;239-267.
11. 3 antagonist binding sites in rat brain. Brain Res. 641:1994;203-207.
12. 3 receptor isoforms with different brain expression and signaling properties. Mol. Pharmacol. 59:2001;1-8.
13. 3R. 29th Annual Meeting of the European Histamine Research Society, Rome, Italy, May 17-21, 2000. 2000;56.
14. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.C., Shankley N.P., Young J.M., Schunack W., Levi R., Haas H.L. International union of pharmacology: 13. Classification of histamine-receptors. Pharmacol. Rev. 49:1997;253-278.
15. Holst B., Hastrup H., Raffetseder U., Martini K., Schwartz T.W. Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis. J. Biol. Chem. 276:2002;19793-19799.
16. Hough L.B. Genomics meets histamine receptors: new subtypes, new receptors. Mol. Pharmacol. 59:2001;415-419.
17. 3 receptors in the human heart. Circ. Res. 77:1995;206-210.
18. 3 receptor binding assay using the iodinated analog of the imidazole-free antagonist and inverse agonist JB98064 as a ligand. 31st Annual Meeting of the European Histamine Research Society, Eger, Hungary, May 22-26, 2002. 2002;21.
19. 3 receptor agonists and antagonists. Trends Pharmacol. Sci. 19:1998;177-183.
20. Leurs R., Smit M.J., Alewijnse A.E., Timmerman H. Agonist-independent regulation of constitutively active G-protein-coupled receptors. Trends Biochem. Sci. 23:1998;418-422.
21. Leurs R., Sol Rodriguez Pena M., Bakker R.A., Alewijnse A.E., Timmerman H. Constitutive activity of G protein coupled receptors and drug action. Pharm. Acta Helv. 74:2000;327-331.
22. 3 antagonists. XXXth Annual Meeting of the European Histamine Research Society, Turku, Finland, May 9-12, 2001. 2001;32.
23. 3 receptors. J. Pharmacol. Exp. Ther. 271:1994;452-459.
24. 3-receptor antagonist. J. Pharmacol. Exp. Ther. 287:1998;658-666.
25. 3 receptors: role of two amino acids in the third transmembrane domain. Br. J. Pharmacol. 131:2000;1247-1250.
26. 3 receptor antagonists. J. Med. Chem. 43:2000;2362-2370.
27. 3 receptor mRNA at the third cytoplasmic loop is not detectable in humans. Mol. Brain Res. 83:2000;145-150.
28. 4 receptors reveals substantial pharmacological species variation. J. Pharmacol. Exp. Ther. 299:2001;121-130.
29. 3 receptor. Mol. Pharmacol. 55:1999;1101-1107.
30. 3 receptor reveals distinct species pharmacological profiles. J. Pharmacol. Exp. Ther. 293:2000;771-778.
31. Milligan G., Bond R.A., Lee M. Inverse agonism - pharmacological curiosity or potential therapeutic strategy. Trends Pharmacol. Sci. 16:1995;10-13.
32. 3 receptors regulates histamine neurons in brain. Nature. 408:2000;860-864.
33. 3 receptor: gene organization and multiple isoforms. Biochem. Biophys. Res. Commun. 280:2001;75-80.
34. 3 receptors. Br. J. Pharmacol. 135:2002;383-392.
35. 3 receptor with high in vitro and in vivo activity. J. Med. Chem. 42:1999;4269-4274.
36. 3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 337:1988;588-590.
37. 3 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 340:1989;633-638.
38. 3 receptors. J. Neural Transm. 93:1993;1-10.
39. 3 receptor heterogeneity. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;482-488.
40. 3 receptor. J. Med. Chem. 39:1996;1220-1226.
41. 3 receptor: evidence for two isoforms. NeuroReport. 11:2000;755-759.
42. 3 receptor gene. NeuroReport. 12:2001;321-324.
43. 3 receptor antagonists, in 2 functional models. Eur. J. Pharmacol. 351:1998;307-311.
44. 3 receptor ligands. J. Pharmacol. Exp. Ther. 289:1999;1160-1168.
45. 3 receptor antagonists. Expert Opin. Ther. Pat. 10:2000;1045-1055.
46. van der Goot H., Timmerman H. Selective ligands as tools to study histamine receptors. Eur. J. Med. Chem. 35:2000;5-20.
47. 3 receptor. Abstract from the International Sendai Histamine Symposium, Sendai, Japan, November 20-25, 2000. 2000;50.
48. 3-histamine receptor subtypes. Mol. Pharmacol. 38:1990;610-613.
49. 3H]N-α-methylhistamine binding differ from that of rodents. Eur. J. Pharmacol. 377:1999;233-239.
50. 3 antagonists. J. Pharmacol. Exp. Ther. 299:2001;908-914.
51. 3 receptors inhibits renal noradrenergic neurotransmission in anesthetized dogs. Am. J. Physiol., Regul. Integr. Comp. Physiol. 280:2001;R1450-R1456.
52. 3 receptor antagonist, GT2394, on food intake and weight gain in Sprague-Dawley rats. Soc. Neurosci. Abstr. 26:2000;279.